• 1. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Sugar acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Sugar acids and derivatives

Introduction to Valproic Acid β-D-Glucuronide (CAS No: 60113-83-9)

Valproic Acid β-D-Glucuronide, with the chemical identifier CAS No 60113-83-9, is a significant metabolite of Valproic Acid (VPA), a widely used anticonvulsant and mood-stabilizing drug. This compound has garnered increasing attention in the field of pharmacology and medicinal chemistry due to its unique pharmacokinetic properties and potential therapeutic applications. Understanding its structure, biosynthesis, and biological significance is crucial for optimizing drug formulations and improving patient outcomes.

The chemical structure of Valproic Acid β-D-Glucuronide consists of a carboxylic acid derivative of VPA conjugated with β-D-glucuronic acid through an ester linkage. This glucuronidation process is a major pathway for the detoxification and excretion of VPA in the human body. The conjugation with glucuronic acid enhances the water solubility of VPA, facilitating its renal excretion. This metabolic transformation is catalyzed by UDP-glucuronosyltransferases (UGTs), a family of enzymes that play a pivotal role in drug metabolism.

Recent studies have highlighted the importance of Valproic Acid β-D-Glucuronide in modulating the pharmacokinetics of VPA. Research indicates that variations in UGT enzyme activity can significantly influence the levels of this metabolite, thereby affecting the overall efficacy and side-effect profile of VPA therapy. For instance, patients with reduced UGT activity may exhibit higher plasma concentrations of VPA, increasing the risk of adverse effects such as hyperammonemia and liver dysfunction.

The pharmacological significance of Valproic Acid β-D-Glucuronide extends beyond its role as a mere metabolite. Emerging evidence suggests that this compound may possess independent pharmacological activities. Some preliminary studies have indicated that Valproic Acid β-D-Glucuronide might exhibit neuroprotective properties, potentially contributing to its therapeutic benefits in conditions like epilepsy and bipolar disorder. Additionally, its interaction with various biological targets has been explored, revealing possible mechanisms that could be exploited for novel therapeutic strategies.

In clinical settings, the measurement of Valproic Acid β-D-Glucuronide levels can serve as a valuable biomarker for assessing UGT activity and predicting drug-drug interactions. For example, co-administration of drugs that inhibit UGT enzymes can lead to elevated levels of VPA and its metabolites, necessitating dose adjustments to prevent toxicity. This underscores the importance of monitoring Valproic Acid β-D-Glucuronide levels in patients receiving VPA therapy, particularly those on multiple medication regimens.

The synthesis and characterization of Valproic Acid β-D-Glucuronide have been subjects of extensive research in synthetic chemistry. Advanced techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS) have enabled precise quantification and structural elucidation of this compound. These analytical methods are essential for validating experimental findings and ensuring the quality control of pharmaceutical formulations containing VPA or its derivatives.

Future research directions in this field aim to explore the potential therapeutic applications of Valproic Acid β-D-Glucuronide. Given its unique biochemical properties, this metabolite could serve as a lead compound for developing new drugs targeting neurological disorders. Additionally, investigating the regulatory mechanisms governing UGT-mediated glucuronidation may provide insights into enhancing drug bioavailability and reducing metabolic clearance.

The development of novel drug delivery systems has also opened new avenues for studying Valproic Acid β-D-Glucuronide. Techniques such as prodrug design and targeted nanoparticles have been employed to improve the solubility and bioavailability of VPA, thereby influencing the formation and excretion rates of its metabolites. These innovations hold promise for optimizing VPA therapy while minimizing side effects associated with high plasma concentrations.

In conclusion, Valproic Acid β-D-Glucuronide (CAS No: 60113-83-9) is a multifaceted compound with significant implications in pharmacology and medicinal chemistry. Its role as a major metabolite of VPA underscores its importance in drug metabolism and therapy. Ongoing research continues to uncover novel aspects of its pharmacological activity and potential therapeutic applications, making it a subject of great interest in academic and industrial settings.

• 90-80-2(D-(+)-Glucono-1,5-lactone)
• 77-93-0(Triethyl citrate)
• 79-50-5(DL-Pantolactone)
• 87-92-3((2R,3R)-Dibutyl 2,3-dihydroxysuccinate)
• 87-91-2((+)-Diethyl L-tartrate)
• 1080018-94-5(Isosteviol Acyl-β-D-glucuronide)
• 77-89-4(Triethyl O-Acetylcitrate)
• 96-82-2(Lactobionic acid)
• 77-90-7(Tributyl O-Acetylcitrate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)